EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Clinical manifestations and outcomes of otitis media with effusion in adult patients following Omicron infection in China

Xiangming Meng, Ying Wang, Chengzhou Han, Xiaobo Gu, Chao Hang, Jianxun Guo, Yuting Jiang

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2024.10239 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Xiangming Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Chin…. Hauptthemen laut MEDLINE: COVID-19, Otitis Media with Effusion, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Within the constantly changing landscape of the coronavirus disease 2019 (COVID-19) pandemic, the emergence of new variants introduces novel clinical challenges, necessitating the acquisition of updated insights into their impacts on various health conditions. This study investigates the clinical features and therapeutic outcomes of otitis media with effusion (OME) in adults following infection with the Omicron variant of COVID-19, in the context of China ending its “Zero-COVID-19” policy. Conducted as a multicenter, retrospective analysis at two medical institutions in Eastern China from December 2022 to February 2023, the study included patients with confirmed Omicron infection who were diagnosed with OME within two months, adhering to guidelines from the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF). Data on demographics, time from infection to OME manifestation, associated symptoms, and treatment outcomes were collected. Among 68 patients (73 affected ears) with OME post-Omicron infection, common symptoms included cough and nasal obstruction (69.1%). All reported ear fullness, with 86.8% experiencing hearing loss. Tympanic bullae were observed in 72.6% during otoscopy, and most tympanometry results showed a B-type tympanogram (80.0%). An integrated treatment strategy led to an 83.6% cure rate, although 8.2% experienced relapse within 2–3 months. Our findings highlight OME as a prevalent ear complication associated with COVID-19 during the Omicron pandemic, underscoring the necessity for further investigation into its complexities. While the integrated treatment approach proved effective, the 8.2% post-treatment recurrence rate underscores the importance of ongoing monitoring and signals an urgent need for more comprehensive research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Otitis Media with EffusionSARS-CoV-2HumansMaleFemaleAdultChinaMiddle AgedRetrospective StudiesAgedTreatment OutcomeYoung Adult

Autor:innen und Institutionen

  • Department of Otolaryngology, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, China.
  • Department of Otolaryngology, Wuxi Huishan District Qianqiao Street Community Health Service Center, Wuxi, China.

Zitieren

APA

Meng, X., Wang, Y., Han, C., Gu, X., Hang, C., Guo, J., & Jiang, Y. (2024). Clinical manifestations and outcomes of otitis media with effusion in adult patients following Omicron infection in China. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10239

Vancouver

Meng X, Wang Y, Han C, Gu X, Hang C, Guo J, et al. Clinical manifestations and outcomes of otitis media with effusion in adult patients following Omicron infection in China. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10239

BibTeX
@article{Meng2024,
  author = {Meng, Xiangming and Wang, Ying and Han, Chengzhou and Gu, Xiaobo and Hang, Chao and Guo, Jianxun and Jiang, Yuting},
  title = {Clinical manifestations and outcomes of otitis media with effusion in adult patients following Omicron infection in China},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2024.10239}
}
Kostenlos starten →